Physician profile
Joseph Raniere
NPI 1891787586
$6,180.63
in general payments reported to CMS, 2019-2025
21 companies · $3,201 in 2025
The $3,201 reported for 2025 was more than what 89% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $157 · 2020: $522 · 2021: $506 · 2022: $422 · 2023: $742 · 2024: $631 · 2025: $3,201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,217 · Travel and Lodging: $2,031 · Long Term Medical Supply Or Device Loan: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,216.52 |
| Travel and Lodging | $2,031.29 |
| Long Term Medical Supply Or Device Loan | $325.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $2,248.44 | 2024-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Abbvie INC. | $1,019.75 | 2023-2025 | |
| Allergan, INC. | $1,006.00 | 2019-2022 | |
| Integra Lifesciences Corporation | $551.03 | 2019-2025 | Durasorb Monofilament Mesh, Integra, Integra Dermal Regeneration Template |
| Mentor Worldwide LLC | $362.35 | 2020-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Musculoskeletal Transplant Foundation INC. | $306.42 | 2019-2024 | |
| Motiva USA, LLC | $169.65 | 2025 | |
| Boston Scientific Corporation | $151.29 | 2023-2024 | Varithena Administration Pack |
| Polynovo North America LLC | $78.52 | 2023 | |
| Solventum Corporation | $61.66 | 2024 | V.A.C.Ulta, V.A.C. Veraflo, Prevena |
| Organogenesis INC. | $47.60 | 2025 | Puraply Wound Matrix |
| Apollo Endosurgery US INC | $28.78 | 2019 | |
| Axogen | $27.76 | 2025 | |
| Acera Surgical, INC. | $27.09 | 2024 | Restrata Wound Matrix |
| Bard Peripheral Vascular, INC. | $21.58 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tepha INC | $20.12 | 2019 | |
| Medline Industries LP | $15.59 | 2024 | |
| Galderma Laboratories, L.P. | $14.02 | 2019 | |
| Coopersurgical, INC. | $12.85 | 2022 | |
| Apyx Medical Corporation | $10.13 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Raniere listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.